日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in Thailand

利用泰国高价抗癌药物的真实数据对管理准入协议技术进行成本比较评估

期刊:Journal of Market Access Health Policy
影响因子:
doi:10.3390/jmahp14010017
Owat, Piyapat; Sooksriwong, Chaoncin; Ratanabunjerdkul, Hataiwan; Phodha, Tuangrat
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Unlocking access: a comprehensive analysis of medicines accessibility for rare diseases in Thailand

解锁获取途径：泰国罕见病药物可及性综合分析

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-025-03754-9
Suwattanapreeda, Siriwat; Hirunrassamee, Sanita; Sooksriwong, Chaoncin; Maluangnon, Kusawadee; Chuachantra, Thirapich; Kuchaisit, Krissana; Osirisakul, Niti
发表日期：2025
文献求助 收藏

Biosimilars in practice: Discriminant factors influencing prescription decisions among physicians in Thailand

生物类似药的实际应用：影响泰国医生处方决策的判别因素

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0327591
Sooksriwong, Chaoncin; Kachai, Ekapong; Katchamart, Wanruchada; Rojnuckarin, Ponlapat; Sirachainan, Ekaphop; Phodha, Tuangrat
发表日期：2025
文献求助 收藏

Monitoring the impact of regulatory measures on medicine pricing in Thailand: an observation over a 16-year span

监测泰国药品定价监管措施的影响：一项为期16年的观察研究

期刊:Journal of Pharmaceutical Policy and Practice
影响因子:2.5
doi:10.1080/20523211.2025.2465801
Sooksriwong, Chaoncin; Hirunrassamee, Sanita; Suwattanapreeda, Siriwat; Maluangnon, Kusawadee; Chuachantra, Thirapich; Babar, Zaheer-Ud-Din; Kuchaisit, Krissana; Osirisakul, Niti
发表日期：2025
文献求助 收藏

The national budget impact of managed entry agreement strategies match with high-cost drugs to maximise drug cost saving: a study protocol

国家预算对通过管理准入协议策略匹配高价药物以最大限度节省药品成本的影响：一项研究方案

期刊:Journal of Pharmaceutical Policy and Practice
影响因子:2.5
doi:10.1080/20523211.2024.2428395
Owat, Piyapat; Sooksriwong, Chaoncin; Ratanabunjerdkul, Hataiwan; Phodha, Tuangrat
发表日期：2024
文献求助 收藏